JP2025517123A5 - - Google Patents

Info

Publication number
JP2025517123A5
JP2025517123A5 JP2024564846A JP2024564846A JP2025517123A5 JP 2025517123 A5 JP2025517123 A5 JP 2025517123A5 JP 2024564846 A JP2024564846 A JP 2024564846A JP 2024564846 A JP2024564846 A JP 2024564846A JP 2025517123 A5 JP2025517123 A5 JP 2025517123A5
Authority
JP
Japan
Application number
JP2024564846A
Other languages
Japanese (ja)
Other versions
JPWO2023217437A5 (https=
JP2025517123A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/056392 external-priority patent/WO2023217437A1/en
Publication of JP2025517123A publication Critical patent/JP2025517123A/ja
Publication of JPWO2023217437A5 publication Critical patent/JPWO2023217437A5/ja
Publication of JP2025517123A5 publication Critical patent/JP2025517123A5/ja
Pending legal-status Critical Current

Links

JP2024564846A 2022-05-13 2023-03-13 アルツハイマー病の処置のためのHNRNP R-媒介Mapt mRNA輸送の遮断を介する軸索タウ(tau)タンパク質蓄積を減少させるための方法及び分子 Pending JP2025517123A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263364629P 2022-05-13 2022-05-13
US63/364,629 2022-05-13
US202263382536P 2022-11-07 2022-11-07
US63/382,536 2022-11-07
PCT/EP2023/056392 WO2023217437A1 (en) 2022-05-13 2023-03-13 Method and molecules for reducing axonal tau protein accumulation through blocking of hnrnp r-mediated mapt mrna transport for treatment of alzheimer's disease

Publications (3)

Publication Number Publication Date
JP2025517123A JP2025517123A (ja) 2025-06-03
JPWO2023217437A5 JPWO2023217437A5 (https=) 2025-12-09
JP2025517123A5 true JP2025517123A5 (https=) 2025-12-09

Family

ID=85685250

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024564846A Pending JP2025517123A (ja) 2022-05-13 2023-03-13 アルツハイマー病の処置のためのHNRNP R-媒介Mapt mRNA輸送の遮断を介する軸索タウ(tau)タンパク質蓄積を減少させるための方法及び分子

Country Status (6)

Country Link
US (1) US20250304958A1 (https=)
EP (1) EP4522217A1 (https=)
JP (1) JP2025517123A (https=)
AU (1) AU2023267136A1 (https=)
CA (1) CA3246379A1 (https=)
WO (1) WO2023217437A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI772856B (zh) * 2013-07-19 2022-08-01 美商百健Ma公司 用於調節τ蛋白表現之組合物
AU2016215155A1 (en) * 2015-02-04 2017-08-17 F. Hoffmann-La Roche Ag Tau antisense oligomers and uses thereof
AU2021238319A1 (en) * 2020-03-18 2022-10-06 University Of Massachusetts Oligonucleotides for MAPT modulation

Similar Documents

Publication Publication Date Title
JP2024539596A5 (https=)
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13149U (https=)
BY13159U (https=)
BY13140U (https=)
BY13141U (https=)
BY13175U (https=)
BY13143U (https=)
BY13144U (https=)
BY13145U (https=)
BY13174U (https=)